It has been reported that inhibition of TNF-α levels can reduce systolic blood pressure and relieve left ventricular hypertrophy and activate the Akt/eNOS pathway to improve vascular endothelial function [47]. The gene discussed is AKT1; the disease is left ventricular hypertrophy.